Codexis logo

Codexis Share Price Today

(NASDAQ: CDXS)

Codexis share price is $2.73 & ₹237.43 as on 6 Mar 2025, 2.30 'hrs' IST

$2.73

▲

0.05

(1.87%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Codexis share price in Dollar and Rupees. Guide to invest in Codexis stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Codexis, along with analyst recommendations, forecasts, and comprehensive financials.

Codexis share price movements

  • Today's Low: $2.62
    Today's High: $2.81

    Day's Volatility :6.6%

  • 52 Weeks Low: $2.48
    52 Weeks High: $6.08

    52 Weeks Volatility :59.21%

Codexis (CDXS) Returns

PeriodCodexis, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-41.04%
3.7%
0.0%
6 Months
-2.85%
-2.8%
0.0%
1 Year
-25.0%
2.5%
0.0%
3 Years
-85.39%
12.9%
-11.6%

Codexis (CDXS) Key Statistics

in dollars & INR

Previous Close
$2.68
Open
$2.71
Today's High
$2.805
Today's Low
$2.62
Market Capitalization
$222.0M
Today's Volume
$1.3M
52 Week High
$6.08
52 Week Low
$2.48
Revenue TTM
$59.3M
EBITDA
$-53.4M
Earnings Per Share (EPS)
$-0.87
Profit Margin
-109.99%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-85.03%

How to invest in Codexis Stock (CDXS) from India?

It is very easy for Indian residents to invest directly in Codexis from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Codexis stock in both Indian Rupees (INR) and US Dollars (USD). Search for Codexis or CDXS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Codexis or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Codexis shares which would translate to 0.319 fractional shares of Codexis as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Codexis, in just a few clicks!

Returns in Codexis (CDXS) for Indian investors in Rupees

The Codexis stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Codexis investment value today

Current value as on today

₹79,949

Returns

₹20,051

(-20.05%)

Returns from Codexis Stock

₹25,000 (-25%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Codexis (CDXS)

-20%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Codexis Stock from India on INDmoney has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Codexis

  • Opaleye Management Inc

    10.67%

  • Casdin Capital, LLC

    9.78%

  • BlackRock Inc

    9.23%

  • FMR Inc

    5.46%

  • Vanguard Group Inc

    5.39%

  • Telemark Asset Management, LLC

    3.62%

Analyst Recommendation on Codexis

Buy

    84%Buy

    15%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Codexis(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
10
Hold
2
2
3
Sell
0
0
0

Analyst Forecast on Codexis Stock (CDXS)

What analysts predicted

Upside of 168.62%

Target:

$7.33

Current:

$2.73

Insights on Codexis Stock (Ticker Symbol: CDXS)

  • Price Movement

    In the last 7 days, CDXS stock has moved down by -30.5%

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 7.97M → 21.46M (in $), with an average increase of 39.0% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -22.75M → -10.37M (in $), with an average increase of 54.6% per quarter

  • CDXS vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 91.5%

  • CDXS vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 137.5%

  • Price to Sales

    ForCDXS every $1 of sales, investors are willing to pay $3.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

CDXS Codexis Financials in INR & Dollars

FY19Y/Y Change
Revenue
$68.5M
↑ 12.98%
Net Income
$-11.9M
↑ 9.72%
Net Profit Margin
-17.43%
↑ 0.52%
FY20Y/Y Change
Revenue
$69.1M
↑ 0.87%
Net Income
$-24.0M
↑ 101.17%
Net Profit Margin
-34.77%
↓ 17.34%
FY21Y/Y Change
Revenue
$104.8M
↑ 51.69%
Net Income
$-21.3M
↓ 11.37%
Net Profit Margin
-20.31%
↑ 14.46%
FY22Y/Y Change
Revenue
$138.6M
↑ 32.3%
Net Income
$-33.6M
↑ 57.86%
Net Profit Margin
-24.24%
↓ 3.93%
FY23Y/Y Change
Revenue
$70.1M
↓ 49.39%
Net Income
$-76.2M
↑ 126.96%
Net Profit Margin
-108.69%
↓ 84.45%
FY24Y/Y Change
Revenue
$59.3M
↓ 15.39%
Net Income
$-65.3M
↓ 14.38%
Net Profit Margin
-109.99%
↓ 1.3%
Q3 FY23Q/Q Change
Revenue
$9.3M
↓ 56.49%
Net Income
$-34.9M
↑ 202.94%
Net Profit Margin
-376.29%
↓ 322.25%
Q4 FY23Q/Q Change
Revenue
$26.6M
↑ 186.31%
Net Income
$-7.2M
↓ 79.4%
Net Profit Margin
-27.08%
↑ 349.21%
Q1 FY24Q/Q Change
Revenue
$17.1M
↓ 35.72%
Net Income
$-11.5M
↑ 59.97%
Net Profit Margin
-67.39%
↓ 40.31%
Q2 FY24Q/Q Change
Revenue
$8.0M
↓ 53.27%
Net Income
$-22.8M
↑ 97.78%
Net Profit Margin
-285.19%
↓ 217.8%
Q3 FY24Q/Q Change
Revenue
$12.8M
↑ 60.83%
Net Income
$-20.6M
↓ 9.29%
Net Profit Margin
-160.84%
↑ 124.35%
Q4 FY24Q/Q Change
Revenue
$21.5M
↑ 67.23%
Net Income
$-10.4M
↓ 49.73%
Net Profit Margin
-48.35%
↑ 112.49%
FY19Y/Y Change
Profit
$52.8M
↑ 10.11%
FY20Y/Y Change
Profit
$55.3M
↑ 4.71%
FY21Y/Y Change
Profit
$82.5M
↑ 49.23%
FY22Y/Y Change
Profit
$100.6M
↑ 21.82%
FY23Y/Y Change
Profit
$57.3M
↓ 42.98%
FY24Y/Y Change
Profit
$43.1M
↓ 24.9%
Q3 FY23Q/Q Change
Profit
$7.0M
↓ 61.27%
Q4 FY23Q/Q Change
Profit
$22.5M
↑ 219.91%
Q1 FY24Q/Q Change
Profit
$11.0M
↓ 51.23%
Q2 FY24Q/Q Change
Profit
$3.3M
↓ 70.11%
Q3 FY24Q/Q Change
Profit
$8.5M
↑ 159.79%
Q4 FY24Q/Q Change
Profit
$17.8M
↑ 109.09%
FY19Y/Y Change
Operating Cash Flow
$-12.6M
↓ 10.88%
Investing Cash Flow
$-3.7M
↑ 32.5%
Financing Cash Flow
$54.0M
↑ 39.91%
FY20Y/Y Change
Operating Cash Flow
$-16.5M
↑ 31.08%
Investing Cash Flow
$-5.7M
↑ 56.83%
Financing Cash Flow
$80.8M
↑ 49.75%
FY21Y/Y Change
Operating Cash Flow
$-14.3M
↓ 13.34%
Investing Cash Flow
$-21.4M
↑ 272.69%
Financing Cash Flow
$3.8M
↓ 95.34%
FY22Y/Y Change
Operating Cash Flow
$11.3M
↓ 179.09%
Investing Cash Flow
$-13.6M
↓ 36.62%
Financing Cash Flow
$-575.0K
↓ 115.26%
Q3 FY23Q/Q Change
Operating Cash Flow
$-16.3M
↑ 1.34%
Investing Cash Flow
$-1.1M
↓ 29.54%
Financing Cash Flow
$-108.0K
↓ 101.56%

Codexis Technicals Summary

Sell

Neutral

Buy

Codexis is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Codexis (CDXS) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Codexis, Inc. logo
Codexis, Inc.
-38.65%
-2.85%
-25.0%
-85.39%
-76.12%
Regeneron Pharmaceuticals, Inc. logo
Regeneron Pharmaceuticals, Inc.
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
Beone Medicines Ltd
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
Alnylam Pharmaceuticals, Inc.
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Codexis, Inc. logo
Codexis, Inc.
NA
NA
-1.16
-0.54
-0.85
-0.26
NA
0.82
Regeneron Pharmaceuticals, Inc. logo
Regeneron Pharmaceuticals, Inc.
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
Beone Medicines Ltd
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Codexis, Inc. logo
Codexis, Inc.
Buy
$222.0M
-76.12%
NA
-109.99%
Regeneron Pharmaceuticals, Inc. logo
Regeneron Pharmaceuticals, Inc.
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
Beone Medicines Ltd
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
126.66%
NA
-12.37%

About Codexis

Codexis, Inc. discovers, develops, and sells enzymes and other proteins using its proprietary CodeEvolver platform. Its technology platform helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company offers enzymes to solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. It is also developing its proprietary ECO Synthesis(tm) manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. The company offers biocatalyst products and services. It also provides biocatalyst screening and protein engineering services. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Organization
Codexis
Employees
188
CEO
Dr. Stephen George Dilly MBBS, Ph.D.
Industry
Process Industries

Management People of Codexis

NameTitle
Dr. Stephen George Dilly MBBS, Ph.D.
President, CEO & Chairman
Mr. Kevin Norrett M.B.A., M.S.
Chief Operating Officer
Dr. Alison Moore Ph.D.
Chief Technology Officer
Ms. Georgia L. Erbez
Chief Financial Officer
Ms. Carrie McKim
Director of Investor Relations
Ms. Karen Frechou-Armijo
Senior VP & Head of Human Resources
Dr. Stefan Lutz Ph.D.
Senior Vice President of Research
Mr. John Schiffhauer
Senior Vice President of Intellectual Property

Important FAQs about investing in CDXS Stock from India :

What is Codexis share price today?

Codexis share price today stands at $2.73, Open: $2.71 ; Previous Close: $2.68 ; High: $2.81 ; Low: $2.62 ; 52 Week High: $6.08 ; 52 Week Low: $2.48.

The stock opens at $2.71, after a previous close of $2.68. The stock reached a daily high of $2.81 and a low of $2.62, with a 52-week high of $6.08 and a 52-week low of $2.48.

Can Indians buy Codexis shares?

Yes, Indians can invest in the Codexis (CDXS) from India.

With INDmoney, you can buy Codexis at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Codexis at zero transaction cost.

How can I buy Codexis shares from India?

It is very easy to buy Codexis from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Codexis (CDXS) be purchased?

Yes, you can buy fractional shares of Codexis with INDmoney app.

What are the documents required to start investing in Codexis stocks?

To start investing in Codexis, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Codexis Stock (CDXS)?

Today’s highest price of Codexis (CDXS) is $2.81.

Today’s lowest price of Codexis (CDXS) is $2.62.

What is today's market capitalisation of Codexis?

Today's market capitalisation of Codexis CDXS is 222.0M

What is the 52 Week High and Low Range of Codexis Stock (CDXS)?

  • 52 Week High

    $6.08

  • 52 Week Low

    $2.48

What are the historical returns of Codexis (CDXS)?

  • 1 Month Returns

    -38.65%

  • 3 Months Returns

    -2.85%

  • 1 Year Returns

    -25%

  • 5 Years Returns

    -76.12%

Who is the Chief Executive Officer (CEO) of Codexis ?

Dr. Stephen George Dilly MBBS, Ph.D. is the current Chief Executive Officer (CEO) of Codexis.